Skip to main content
. 2016 Jun 30;2016(6):CD012161. doi: 10.1002/14651858.CD012161

Iwamoto 2001.

Methods Parallel randomised controlled clinical trial
Randomisation ratio: 2:1
Participants Inclusion criteria: diabetes duration > 2 years, insulin treatment > 1 year, capable of coping with hypoglycaemia, 1‐3 times insulin injection, blood glucose ‐ self monitoring, HbA1c < 11%, BMI < 30, aged > 12 years
Exclusion criteria: ‐
Diagnostic criteria: ‐
Interventions Number of study centres: multicentre (number of centres not reported)
Treatment before study: insulin treatment > 1 year
Titration period: 168 days (24 weeks)
Insulin aspart vs. RHI (see Appendix 2)
Outcomes Outcomes reported in abstract of publication: change in HbA1c, blood glucose 90 minutes after breakfast, adverse events, insulin antibodies
Primary outcome(s):
Secondary outcome(s):
Other outcome(s):
Study details Run‐in period: 6 weeks
Study terminated before regular end: no
Publication details Language of publication: Japanese
Funding: commercial (Novo Nordisk)
Publication status: peer‐reviewed journal/full article
Stated aim for study Quote from publication: "The efficacy and safety of insulin aspart, a rapid‐acting insulin, were investigated in type 1 diabetes patients treated in basal‐bolus regimen compared to soluble human insulin"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: not described
Allocation concealment (selection bias) Unclear risk Comment: not described
Blinding of participants and personnel (performance bias) 
 Objective outcomes High risk Comment: unblinded
Blinding of participants and personnel (performance bias) 
 Subjective outcomes High risk Comment: unblinded
Blinding of outcome assessment (detection bias) 
 Objective outcomes Unclear risk Comment: HbA1c measured at a central laboratory
Blinding of outcome assessment (detection bias) 
 Subjective outcomes Unclear risk Comment: not known
Incomplete outcome data (attrition bias) 
 Objective outcomes High risk Comment: number of drop‐outs reported, but no details; analysis seems to be complete case
Incomplete outcome data (attrition bias) 
 Subjective outcomes High risk Comment: number of drop‐outs reported, but no details; analysis seems to be complete case
Selective reporting (reporting bias) Unclear risk Comment: not enough information to make judgement on selective reporting
Other bias Unclear risk Comment: not enough information on data analysis